With in-person events back again, Creative Biolabs is excited to greet you at the upcoming international conferences. Meet our team at 2022 BIO International Convention in June (booth #1754) and at the 13th Annual World ADC San Diego in September (booth number to be updated) for expert consultation on your drug discovery. Shoot an email to arrange an in-person meeting!
Figure 1 The FcγRIIa-H ADCP Reporter Bioassay reflects the MOA and specificity of antibodies designed to bind and activate FcγRIIa-H. Panels A and B. Increasing concentrations of trastuzumab (anti-HER2) or rituximab (anti-CD20) were incubated with either SKBR3 (HER2+) or Raji (CD20+) target cells and FcγRIIa-H Eff ector Cells, as indicated.
All products and services are for Research Use Only. Do Not use in humans.
Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.